Fundraising Fox
Flomics
1 known investors
Find your way into Flomics
Sign up to see every warm intro you have to Flomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Flomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.
Founders & leadership
JC
João CuradoCEO & Co-founderJoão Curado is CEO and co-founder of Flomics, a liquid biopsy company developing next-generation sequencing and machine learning-based tests for cancer and disease detection from blood samples. He has expertise in genomics, bioinformatics, and statistical analysis, with a background in academic research.
EL
Esther LizanoScientific Advisor & Co-founder
LK
Luís KorrodiBusiness Advisor & Co-founderBusiness Advisor and co-founder of Flomics, which develops next-generation sequencing and machine learning-based liquid biopsy tests for cancer and disease diagnostics alongside end-to-end genomics services. He holds a PhD in Biochemistry and a Master's in Business Management applied to Project Management, with experience in healthcare and business development.
AG
André GuedesCOO & Co-founderAndré Guedes holds a PhD in Physics and has built technology companies in biotech and deep tech, with experience in operations, partnerships, and fundraising across Europe and Silicon Valley. He is co-founder and COO of Flomics, which develops liquid biopsy tests using sequencing and machine learning to detect cancer and other complex diseases from blood samples.
Investors · 1
In the news
Frequently asked questions
- What does Flomics do?
- Flomics develops liquid biopsy tests using next-generation sequencing and machine learning to detect cancer and other complex diseases from blood samples for clinical diagnostics. The company also provides end-to-end genomics solutions including data generation, analysis, and bioinformatics support for research and clinical projects.
- Who founded Flomics?
- Flomics was founded by João Curado, Esther Lizano, Luís Korrodi, André Guedes.
- Who are Flomics's investors?
- Flomics's investors include Capital Cell.